Angela Zumstein > MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH > Munich, Germany > Lawyer Profile

MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH
MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH
ELISENSTRASSE 3, 80335 MÜNCHEN
Germany
Angela Zumstein photo

Work Department

Angela Zumstein studied pharmacy at the Ludwig-Maximilians-Universität in Munich.  Part of her patent attorney training was carried out in the patent department of an internationally-operating Swiss pharma concern, where she gained valuable insights into the patent strategies of the pharmaceutical industry. Since she is the third generation of her family to choose the career of a patent attorney, she has particular knowledge of organic chemistry, especially in the fields of special chemicals, polymer chemistry and chemical process engineering.  She also assists clients in obtaining and enforcing supplementary protection certificates across the whole of the EEA.  In addition to managing international IP portfolios and securing supplementary protection certificates for clients’ intellectual property rights, she successfully represents clients in opposition, appeal and nullity proceedings.  She has been praised by clients as “highly professional and willing to understand the client’s issues.”

Position

Partner, German Patent Attorney, European Patent Attorney, European Trademark and Design Attorney

Career

Since 2009

Partner, shareholder and managing director at Maiwald

Since 2009

Patent attorney at Maiwald

2006-2009

Partner at an IP law firm

2003-2006

Patent attorney at an IP law firm

2000-2003

Patent attorney trainee at an IP law firm

 

Languages

German, English, French

Memberships

VPP

Education

2005

Admitted to practice as European patent attorney

2003

Admitted to practice as German patent attorney

2000-2002

Studied law for patent attorneys at the University of Hagen

1993-1998

Studied pharmacy at the Ludwig Maximilian University of München

Lawyer Rankings

Germany > Intellectual property > Patent prosecution

MAIWALD PATENTANWALTS- UND RECHTSANWALTSGESELLSCHAFT MBH fields an active patent granting and opposition procedures practice and has a particular focus on proceedings before the EPO. From its Munich and Düsseldorf offices, the firm also offers advice on strategic patent and portfolio issues, assistance with international instructions such as the global coordination of patent granting procedures, a seasoned team for nullity and infringement claims and advice on complementary protection certificates, which represents a particular focus. Sectorally, the firm’s traditional strength lies in the pharmaceuticals and chemicals industries, although the team also possesses deep expertise in the biotechnology, mechanical engineering, electrotechnology, computer-related inventions and medical engineering fields. The engineering practice is also increasingly gaining visibility. The client base is comprised of startups, medium-sized companies and large international corporations, while the share of clients from the US and Asia, particularly China and Japan, is increasingly growing. The team’s key contacts are Dirk Bühler (biotechnology), Eva Ehlich (chemicals and pharmaceuticals), Martin Huenges (biotechnology and pharmaceuticals), Derk Vos (chemicals and pharmaceuticals), Christian Schäflein (physics), Alexander Ortlieb (physics, medical engineering and diagnostics, computer-implemented inventions, mechanical engineering and telecommunications), Eva Dörner (chemicals), Angela Zumstein (pharmaceuticals), Berthold Lux (chemicals), Alexander Schmitz (electrotechnology) and Sophie Ertl (mechanical engineering). Dually qualified patent lawyer and attorney-at-law Stefan Bianchin joined the firm in February 2019 from Mitscherlich & Partner and made partner in August 2019. Naho Fujimoto (chemicals), Ian Weaver (optoelectronics and optical information processing) and Christian Pioch (software, data processing and semiconductor technology among others) made partner at the end of 2019 and the beginning of 2020 respectively.